Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...
The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives ...
The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at least 56 ...
Incident HCV infection more than doubled among HIV-positive MSM with no history of injection drug use between 1995 and 2023.
Providing feedback following point-of-care urine testing for tenofovir concentrations was associated with increased PrEP ...
HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term protection. If this yearly injection is approved and widely implemented, it ...
Newspoint on MSN16h
Get one injection in a year and get rid of the tension of HIV! It can be a boon for such peopleScientists have got success with a new injection of HIV. Taking this injection once a year can reduce the risk of HIV ...
New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...
Verywell Health on MSN13h
Bacterial Vaginosis May Be Sexually Transmitted, New Study SuggestsA new study in Australia found that treating male partners can reduce BV reinfections, suggesting that BV may be sexually ...
Prof. Francisca Mutapi, a global health expert suggests 4 ways to end the dependence HEALTH | FRANCISCA MUTAPI | There’s been a global trend in the reduction of aid to Africa since 2018. Donors are ...
Measles is unlike other childhood viruses. In severe cases, it can cause pneumonia. About 1 in 1,000 patients develops encephalitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback